Clinical Trials · NCT02478879

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Name: A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Teriparatide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Zosano Pharma Corporation
Enrollment: 24
Start date: Jun 2015
Locations: 1 site, United States
Primary endpoint: Overall Preference

View Teriparatide compound reference